These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 18355849)

  • 1. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux.
    Chi A; Gupta A; Snodgrass W
    J Urol; 2008 May; 179(5):1966-9. PubMed ID: 18355849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
    Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
    J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection.
    Traxel E; DeFoor W; Reddy P; Sheldon C; Minevich E
    J Urol; 2009 Oct; 182(4 Suppl):1708-12. PubMed ID: 19692024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation.
    Elmore JM; Kirsch AJ; Heiss EA; Gilchrist A; Scherz HC
    J Urol; 2008 Jun; 179(6):2364-7; discussion 2367-8. PubMed ID: 18436248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
    Friedmacher F; Colhoun E; Puri P
    J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
    Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
    J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid.
    Sedberry-Ross S; Rice DC; Pohl HG; Belman AB; Majd M; Rushton HG
    J Urol; 2008 Oct; 180(4 Suppl):1605-9; discussion 1610. PubMed ID: 18710762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
    Hunziker M; Mohanan N; Puri P
    J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
    Puri P; Kutasy B; Colhoun E; Hunziker M
    J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
    Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
    J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
    Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
    J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.
    Kobelt G; Canning DA; Hensle TW; Läckgren G
    J Urol; 2003 Apr; 169(4):1480-4; discdussion 1484-5. PubMed ID: 12629396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy.
    Kitchens D; Minevich E; DeFoor W; Reddy P; Wacksman J; Sheldon C; Koyle M
    J Urol; 2006 Oct; 176(4 Pt 2):1861-3. PubMed ID: 16945674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of concomitant autologous blood and dextranomer/hyaluronic acid copolymer injection to correct vesicoureteral reflux.
    Kajbafzadeh AM; Tourchi A
    J Urol; 2012 Sep; 188(3):948-52. PubMed ID: 22819104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction.
    Läckgren G; Sköldenberg E; Stenberg A
    J Urol; 2007 Mar; 177(3):1124-8; discussion 1128-9. PubMed ID: 17296428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.
    Akin Y; Gulmez H; Güntekin E; Baykara M; Yucel S
    Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.
    Ashley R; Vandersteen D
    J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux.
    Yucel S; Gupta A; Snodgrass W
    J Urol; 2007 Apr; 177(4):1505-9. PubMed ID: 17382765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux.
    Puri P; Pirker M; Mohanan N; Dawrant M; Dass L; Colhoun E
    J Urol; 2006 Oct; 176(4 Pt 2):1856-9; discussion 1859-60. PubMed ID: 16945672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management.
    Benoit RM; Peele PB; Docimo SG
    J Urol; 2006 Oct; 176(4 Pt 1):1588-92; discussion 1592. PubMed ID: 16952694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.